PATENT CLAIM ANALYSIS

Application Number: 16237333
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "210200"]

Abstract:
Substituted 1,2,3-triazoles as NR2B receptor ligands. Such compounds may be used in NR2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by NR2B receptor activity.

Claim (Index 30):
A method of treating a subject suffering from or diagnosed with a disease, disorder, or medical condition mediated by NR2B receptor activity, comprising administering to a subject in need of such treatment an effective amount of at least one compound selected from compounds of  claim 1  and pharmaceutically acceptable salts thereof.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 98.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15428710', '16046332', '13503231', '14138941', '15725500']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7690977218807771
- 35 USC 102 Novelty (BERT): 0.6094214295324142
- Combined Prediction Score: 0.7531300926459408
- Mean Citation Score: 440.896106
- Max Citation Score: 546.1803
- Similarity Product: 480.2934494187713

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test